MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dysphagia and dopaminergic neurodegeneration in Parkinson’s Disease

S. Polychronis, B. Ribba, G. Nasios, E. Dardiotis, G. Pagano (Ioannina, Greece)

Meeting: 2023 International Congress

Abstract Number: 1286

Keywords: Parkinson’s

Category: Parkinson's Disease: Pathophysiology

Objective: To evaluate the association between dysphagia and neurodegeneration of the putaminal dopaminergic system in people with early-stage treated with symptomatic therapy and advanced-stage Parkinson’s Disease (PD).

Background: Dysphagia is a common symptom of PD. We have previously demonstrated that people with early-stage drug-naive PD with swallowing difficulties have lower levels of DAT-SPECT in the putamen compared with people with PD without dysphagia.

Method: We included 276 early-treated and 13 advanced PD patients from the Parkinson’s Progression Markers Initiative (PPMI) database in the analysis. We assessed dysphagia using the MDS Unified PD Rating Scale (MDS-UPDRS) Part II, Item 2.3 (Chewing & Swallowing) ≥ 1. The differences in [123I]FP-CIT Single Photon Emission Computed Tomography (SPECT) levels within putamen were investigated in both people with early-stage and advanced-stage PD groups with and without dysphagia. The differences were tested using t-test.

Results: In the early-treated PD group, the prevalence of dysphagia was 18.8% (52/276) and the patients with dysphagia showed lower [123I]FP-CIT uptake in the putamen compared to those without. In the advanced PD group, the prevalence of dysphagia was 61.5% (8/13) and the patients with dysphagia showed lower [123I]FP-CIT uptake in the putamen compared to those without.

Conclusion: Our findings demonstrate that dysphagia is associated with greater loss of putaminal dopaminergic terminals in people with early-stage treated with symptomatic therapy and advanced-stage PD.

To cite this abstract in AMA style:

S. Polychronis, B. Ribba, G. Nasios, E. Dardiotis, G. Pagano. Dysphagia and dopaminergic neurodegeneration in Parkinson’s Disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/dysphagia-and-dopaminergic-neurodegeneration-in-parkinsons-disease/. Accessed September 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dysphagia-and-dopaminergic-neurodegeneration-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Carpal Tunnel Syndrome in Patients with Tremor
  • #23972 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • #22892 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley